U.S. Rep. Dave Joyce (R-OH) said a $3.6 million grant from the U.S. Department of Justice will help an Ohio law enforcement unit crackdown on illegally manufactured and distributed synthetic and prescription opioids.
Joyce announced that the Ohio Organized Crime Investigation Commission received the grant from the U.S. Department of Justice’s Office of Community Oriented Policing services through that office’s Anti-Heroin Task Force program.
“One of my top priorities is to ensure federal funding effectively supports all of the life-saving work Ohio communities are carrying out on the front lines of the opioid crisis,” Joyce said. “I’m proud to have consistently voted to increase funding for the Community Oriented Policing Services Office and look forward to seeing how this $3.6 million grant can help the Ohio Organized Crime Investigations Commission root out illicit drug activity. Drugs like heroin, methamphetamine, and fentanyl have been breaking apart families and threatening the safety of our communities for far too long. I applaud all the great work Ohio Attorney General Dave Yost and our law enforcement officers on the Commission do to prevent these illicit drugs from causing further devastation in the Buckeye State and will continue to do everything I can to support them.”
Established in 1986, the Commission helps local law enforcement agencies combat organized crime and corrupt activities like the manufacturing or trafficking of drugs. The commission is made up of members of the law enforcement community and is chaired by Ohio Attorney General Dave Yost.
“We appreciate the partnership and the additional funding that will be used to disrupt the supply chain of illegal drugs in Ohio,” Yost said. “OOCIC’s interdiction task forces strive to stay a step ahead of the ever-evolving drug dealers who plague on our street and poison our youth. They aren’t stopping, but we aren’t either.”
The grant was part of a nearly $30 million grant program that awarded 14 law enforcement task forces across the country. The grants provide three years of funding to state-level agencies with multijurisdictional reach and interdisciplinary structures in states with high per capita rates of primary treatment admission for opioid use disorder.